Eshleman SH - Search Results

1

Stavudine concentrations in women receiving postpartum antiretroviral treatment and their breastfeeding infants.

Fogel JM, Taha TE, Sun J, Hoover DR, Parsons TL, Kumwenda JJ, Mofenson LM, Fowler MG, Hendrix CW, Kumwenda NI, Eshleman SH, Mirochnick M. Fogel JM, et al. Among authors: eshleman sh. J Acquir Immune Defic Syndr. 2012 Aug 15;60(5):462-5. doi: 10.1097/QAI.0b013e31825ddcfa. J Acquir Immune Defic Syndr. 2012. PMID: 22614899 Free PMC article.

2

Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission.

Jackson JB, Becker-Pergola G, Guay LA, Musoke P, Mracna M, Fowler MG, Mofenson LM, Mirochnick M, Mmiro F, Eshleman SH. Jackson JB, et al. Among authors: eshleman sh. AIDS. 2000 Jul 28;14(11):F111-5. doi: 10.1097/00002030-200007280-00001. AIDS. 2000. PMID: 10983633

3

Safety, tolerability, and antiretroviral effects of ritonavir-nelfinavir combination therapy administered for 48 weeks.

Raines CP, Flexner C, Sun E, Heath-Chiozzi M, Lewis RH, Fields C, Deetz C, Apuzzo L, Eshleman SH, Jackson JB, Gallant JE. Raines CP, et al. Among authors: eshleman sh. J Acquir Immune Defic Syndr. 2000 Dec 1;25(4):322-8. doi: 10.1097/00042560-200012010-00005. J Acquir Immune Defic Syndr. 2000. PMID: 11114832

4

Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).

Eshleman SH, Mracna M, Guay LA, Deseyve M, Cunningham S, Mirochnick M, Musoke P, Fleming T, Glenn Fowler M, Mofenson LM, Mmiro F, Jackson JB. Eshleman SH, et al. AIDS. 2001 Oct 19;15(15):1951-7. doi: 10.1097/00002030-200110190-00006. AIDS. 2001. PMID: 11600822 Clinical Trial.

5

Survival of Ugandan infants with subtype A and D HIV-1 infection (HIVNET 012).

Eshleman SH, Guay LA, Fleming T, Mwatha A, Mracna M, Becker-Pergola G, Musoke P, Mmiro F, Jackson JB. Eshleman SH, et al. J Acquir Immune Defic Syndr. 2002 Nov 1;31(3):327-30. doi: 10.1097/00126334-200211010-00009. J Acquir Immune Defic Syndr. 2002. PMID: 12439209

6

Safety and trough concentrations of nevirapine prophylaxis given daily, twice weekly, or weekly in breast-feeding infants from birth to 6 months.

Shetty AK, Coovadia HM, Mirochnick MM, Maldonado Y, Mofenson LM, Eshleman SH, Fleming T, Emel L, George K, Katzenstein DA, Wells J, Maponga CC, Mwatha A, Jones SA, Abdool Karim SS, Bassett MT; HIVNET 023 Study Team. Shetty AK, et al. Among authors: eshleman sh. J Acquir Immune Defic Syndr. 2003 Dec 15;34(5):482-90. doi: 10.1097/00126334-200312150-00006. J Acquir Immune Defic Syndr. 2003. PMID: 14657758 Clinical Trial.

7

Characterization of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine (HIVNET 012).

Eshleman SH, Guay LA, Mwatha A, Brown ER, Cunningham SP, Musoke P, Mmiro F, Jackson JB. Eshleman SH, et al. J Acquir Immune Defic Syndr. 2004 Feb 1;35(2):126-30. doi: 10.1097/00126334-200402010-00004. J Acquir Immune Defic Syndr. 2004. PMID: 14722443

8

Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP.

Eshleman SH, Hoover DR, Chen S, Hudelson SE, Guay LA, Mwatha A, Fiscus SA, Mmiro F, Musoke P, Jackson JB, Kumwenda N, Taha T. Eshleman SH, et al. J Infect Dis. 2005 Jul 1;192(1):30-6. doi: 10.1086/430764. Epub 2005 Jun 1. J Infect Dis. 2005. PMID: 15942891

9

Comparison of mother-to-child transmission rates in Ugandan women with subtype A versus D HIV-1 who received single-dose nevirapine prophylaxis: HIV Network For Prevention Trials 012.

Eshleman SH, Guay LA, Mwatha A, Brown E, Musoke P, Mmiro F, Jackson JB. Eshleman SH, et al. J Acquir Immune Defic Syndr. 2005 Aug 15;39(5):593-7. J Acquir Immune Defic Syndr. 2005. PMID: 16044013

10

Distinct patterns of emergence and fading of K103N and Y181C in women with subtype A vs. D after single-dose nevirapine: HIVNET 012.

Eshleman SH, Guay LA, Wang J, Mwatha A, Brown ER, Musoke P, Mmiro F, Jackson JB. Eshleman SH, et al. J Acquir Immune Defic Syndr. 2005 Sep 1;40(1):24-9. doi: 10.1097/01.qai.0000174656.71276.d6. J Acquir Immune Defic Syndr. 2005. PMID: 16123677

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

261 results

Search Page